HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

LY2109761

a transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
Networked: 16 relevant articles (3 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Timke, Carmen: 3 articles (07/2012 - 06/2011)
2. Lahn, Michael: 3 articles (07/2012 - 06/2011)
3. Wirkner, Ute: 3 articles (07/2012 - 06/2011)
4. Huber, Peter E: 3 articles (07/2012 - 06/2011)
5. Peschke, Peter: 3 articles (07/2012 - 06/2011)
6. Yingling, Jonathan M: 3 articles (03/2012 - 01/2010)
7. Antonaci, Salvatore: 3 articles (07/2011 - 10/2009)
8. Fransvea, Emilia: 3 articles (07/2011 - 10/2009)
9. Giannelli, Gianluigi: 3 articles (07/2011 - 10/2009)
10. Mazzocca, Antonio: 3 articles (07/2011 - 10/2009)

Related Diseases

1. Neoplasms (Cancer)
2. Neoplasm Metastasis (Metastasis)
3. Carcinoma (Carcinomatosis)
4. Pancreatic Neoplasms (Pancreatic Cancer)
5. Ovarian Neoplasms (Ovarian Cancer)

Related Drugs and Biologics

1. Phosphotransferases (Kinase)
2. Transforming Growth Factor beta Receptors (TGF beta Receptors)
3. Proteins (Proteins, Gene)
4. RNA (Ribonucleic Acid)
5. Luciferases
6. Transforming Growth Factor beta (TGF-beta)
7. Cisplatin (Platino)
8. Neutralizing Antibodies
9. Transforming Growth Factor beta1 (TGF beta 1)
10. Cyclooxygenase 2 (Cyclooxygenase-2)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Radiotherapy
3. Homologous Transplantation (Allograft)
4. Drug Therapy (Chemotherapy)